Patent · US Active

Method and apparatus using magnetic resonance imaging for cancer identification

US8605980B2 · kind B2 · utility

7Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 7, 2009
Grant dateDec 10, 2013
Priority date
Expiry dateJun 12, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01R33/5608
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Embodiments provide a Magnetic Resonance Imaging (MRI) technique and optionally software—collectively referred to as the “shutter-speed” model—to analyze image data of cancer patients. Embodiments provide a minimally invasive, yet precisely accurate, approach to determining whether tumors are malignant or benign by distinguishing the characteristics of contrast reagent activity in benign and malignant tumors. Exemplary embodiments provide MRI measured biomarkers for tumor malignancy determination, effectively eliminating or limiting the false positives suffered by existing MRI techniques.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.